Related Experiment Video
Updated: Jul 10, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Fabry Disease: More than a Phenocopy of Hypertrophic Cardiomyopathy
Kamil Stankowski1,2, Stefano Figliozzi1,2, Vincenzo Battaglia1,2
1Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, 4, Pieve Emanuele, 20090 Milano, Italy.
Insights
Fabry disease (FD) is a genetic disorder causing heart problems. Early diagnosis using cardiac imaging is key for treatment and improving patient outcomes.
Area of Science:
- Cardiology
- Genetics
- Medical Imaging
Background:
- Fabry disease (FD) is a genetic lysosomal storage disorder.
- Cardiovascular involvement is common in FD and impacts clinical outcomes.
- Early recognition of FD is crucial for timely treatment and improved prognosis.
Purpose of the Study:
- To review the role of multimodality cardiac imaging in Fabry disease.
- To explore the diagnostic and prognostic applications of echocardiography and cardiac MRI in FD.
- To highlight the importance of imaging in differentiating FD from other causes of left ventricular hypertrophy.
Main Methods:
- Review of current literature on multimodality cardiac imaging in Fabry disease.
- Focus on echocardiography and cardiovascular magnetic resonance (CMR).
- Evaluation of imaging's role in diagnosis, prognosis, and patient follow-up.
Main Results:
- Multimodality imaging is central to evaluating cardiac involvement in FD.
- Echocardiography and CMR aid in diagnosing FD and assessing its severity.
- Imaging assists in differentiating FD from other conditions causing left ventricular hypertrophy.
Conclusions:
- Multimodality cardiac imaging is essential for managing Fabry disease.
- Early identification of FD through imaging enables timely enzyme replacement therapy.
- Cardiac imaging improves prognostic assessment and follow-up strategies for FD patients.
Abstract:
Fabry disease (FD) is a genetic lysosomal storage disease with frequent cardiovascular involvement, whose presence is a major determinant of adverse clinical outcomes. As a potentially treatable cause of left ventricular hypertrophy (LVH) and heart failure with preserved ejection fraction, the early recognition of FD is crucial to initiate enzyme replacement therapy and improve long-term prognosis. Multimodality imaging plays a central role in the evaluation of patients with FD and helps in the differential diagnosis of other conditions presenting with LVH. In the present review, we explore the current applications of multimodality cardiac imaging, in particular echocardiography and cardiovascular magnetic resonance, in the diagnosis, prognostic assessment, and follow-up of patients with FD.
Related Concept Videos
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

